Comparison of surveillance and retroperitoneal lymph node dissection in Stage I nonseminomatous germ cell tumors

Urology

Volumn 59, Issue 6, 2002, Pages 923-929

  Spermon, J R ^a   Roeleveld, T A ^b   Van der Poel, H G ^b   Hulsbergen van de Kaa, C A ^a   Ten Bokkel Huinink, W W ^b   Van de Vijver, M ^b   Witjes, J A ^a   Horenblas, S ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE;

ADULT; AGE; ARTICLE; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DISSEMINATED CANCER; EMBRYO CELL; FOLLOW UP; HUMAN; HUMAN TISSUE; INFECTION; LEUKOPENIA; LIVER CANCER; LUNG CANCER; LYMPHADENECTOMY; LYMPHOCELE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NEUROPATHY; NON SEMINOMATOUS GERMINOMA; PLEURA CANCER; POPULATION RESEARCH; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROPERITONEAL CANCER; RETROSPECTIVE STUDY; SALVAGE THERAPY; SCROTUM DISORDER; SMALL INTESTINE OBSTRUCTION; SURGICAL TECHNIQUE; SURVIVAL RATE; TESTIS CARCINOMA; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; EJACULATION; GERMINOMA; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROPERITONEAL SPACE; RETROSPECTIVE STUDIES; SENTINEL SURVEILLANCE; TESTICULAR NEOPLASMS;

EID: 0036094087     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)01528-5     Document Type: Article

References (20)

1. Medical Research Council Testicular Tumors Working Party: Medical Research Council prospective study of surveillance for stage I testicular teratoma
2. Primary retroperitoneal lymph node dissection in clinical stage A non-seminomatous germ cell testis cancer: Review of the Indiana University experience 1965-1989
3. Orchidectomy alone in testicular stage I non-seminomatous germ-cell tumors
4. Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis
5. Staging relationships and outcome in early stage testicular cancer: A report from the Testicular Cancer Intergroup Study
6. Results and outcome of retroperitoneal lymph node dissection for clinical stage I embryonal carcinoma - Predominant testis cancer
7. Risk adapted management with adjuvant chemotherapy in patients with high risk clinical stage I nonseminomatous germ cell tumor
8. Adjuvant chemotherapy for high-risk clinical stage I nonseminomatous testicular germ cell cancer: Long-term results of a prospective trial
9. Non-seminoma germ cell tumours (malignant teratoma) of the testis: Results of treatment and an analysis of prognostic factors
10. Complications of retroperitoneal lymph node dissection in testicular cancer: Primary and post-chemotherapy
11. CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: Assessment of size and distribution criteria
12. Positron emission tomography in the clinical staging of patients with Stage I and II testicular germ cell tumors
13. Stage I nonseminomatous germ-cell testicular cancer - Management options and risk-benefit considerations
14. Late results of surveillance of clinical stage I nonseminoma germ cell testicular tumors: 17 years' experience in a national study in New Zealand
15. Compliance of clinical stage I nonseminomatous germ cell tumor patients with surveillance
16. Retroperitoneal recurrences after retroperitoneal lymph node dissection for low-stage nonseminomatous germ cell tumors
17. Testicular germ-cell cancer
18. Testicular cancer: The psychosocial problems of patients and their relatives
19. Complications of primary retroperitoneal lymph node dissection
20. Retroperitoneal lymph node dissection for the management of clinical stage I nonseminoma